Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic sells and services its products through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Hologic Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Hologic Inc Company Overview 6
Hologic Inc Company Snapshot 6
Hologic Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Hologic Inc – Pipeline Analysis Overview 9
Business Description 9
Hologic Inc - Key Facts 9
Hologic Inc - Major Products and Services 10
Hologic Inc Pipeline Products by Development Stage 14
Hologic Inc Ongoing Clinical Trials by Trial Status 16
Hologic Inc Pipeline Products Overview 18
Aptima Assay - BV 18
Aptima Assay - BV Product Overview 18
Aptima Assay - Candida 19
Aptima Assay - Candida Product Overview 19
APTIMA HBV Quant Assay 20
APTIMA HBV Quant Assay Product Overview 20
Aptima HSV 1 & 2 Assay 21
Aptima HSV 1 & 2 Assay Product Overview 21
Brevera Biopsy System 22
Brevera Biopsy System Product Overview 22
Cytology System 23
Cytology System Product Overview 23
Diagnostic Assay - Coagulation Disorders 24
Diagnostic Assay - Coagulation Disorders Product Overview 24
Diagnostic Assay - HBV 25
Diagnostic Assay - HBV Product Overview 25
Diagnostic Assay - HCV 26
Diagnostic Assay - HCV Product Overview 26
Diagnostic Assay - Women's Health 27
Diagnostic Assay - Women's Health Product Overview 27
Gene-Based Markers - Prostate Cancer 28
Gene-Based Markers - Prostate Cancer Product Overview 28
Invader CYP2C9 And VKORC1 DNA Assay 29
Invader CYP2C9 And VKORC1 DNA Assay Product Overview 29
LBC Automation Standalone Instrument 30
LBC Automation Standalone Instrument Product Overview 30
MRSA Nucleic Acid Test 31
MRSA Nucleic Acid Test Product Overview 31
Next Generation Panther Fusion 32
Next Generation Panther Fusion Product Overview 32
Panther Fusion - Paraflu Assay 33
Panther Fusion - Paraflu Assay Product Overview 33
Panther System - HSV-2 Assay 34
Panther System - HSV-2 Assay Product Overview 34
PANTHER System - Virology 35
PANTHER System - Virology Product Overview 35
Procleix Panther system 36
Procleix Panther system Product Overview 36
Procleix Panther system Clinical Trial 37
Procleix Zika Virus Assay 38
Procleix Zika Virus Assay Product Overview 38
Procleix Zika Virus Assay Clinical Trial 39
Quant. fFN Test 40
Quant. fFN Test Product Overview 40
Real Time PCR Next Generation PANTHER System 41
Real Time PCR Next Generation PANTHER System Product Overview 41
Second-Generation Prostate Cancer Assay 42
Second-Generation Prostate Cancer Assay Product Overview 42
STAT Testing 43
STAT Testing Product Overview 43
Hologic Inc - Key Competitors 44
Hologic Inc - Key Employees 45
Hologic Inc - Key Employee Biographies 46
Hologic Inc - Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Affiliate 50
Recent Developments 51
Hologic Inc, Recent Developments 51
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 51
Feb 15, 2017: FDA Grants PMA Approval for Hologic's Aptima Hepatitis C Quant Dx Assay 51
Feb 13, 2017: Hologic's Aptima Zika Virus Assay Now CE Marked in Europe 52
Feb 02, 2017: Hologic Launches Next-Generation NovaSure ADVANCED Global Endometrial Ablation System For The Treatment Of Abnormal Uterine Bleeding 52
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 53
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 54
Jan 03, 2017: FDA Grants PMA Approval for Hologic's Aptima HIV-1 Quant Assay 54
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 55
Nov 25, 2016: Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 55
Nov 15, 2016: Hologic Obtains European CE Mark for Aptima Assay to Detect Herpes Simplex Virus 1 & 2 56
Appendix 58
Methodology 58
About GlobalData 60
Contact Us 60
Disclaimer 60
List of Tables
Hologic Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Hologic Inc Pipeline Products by Equipment Type 7
Hologic Inc Pipeline Products by Indication 8
Hologic Inc Ongoing Clinical Trials by Trial Status 8
Hologic Inc, Key Facts 9
Hologic Inc, Major Products and Services 10
Hologic Inc Number of Pipeline Products by Development Stage 14
Hologic Inc Pipeline Products Summary by Development Stage 15
Hologic Inc Ongoing Clinical Trials by Trial Status 16
Hologic Inc Ongoing Clinical Trials Summary 17
Aptima Assay - BV - Product Status 18
Aptima Assay - BV - Product Description 18
Aptima Assay - Candida - Product Status 19
Aptima Assay - Candida - Product Description 19
APTIMA HBV Quant Assay - Product Status 20
APTIMA HBV Quant Assay - Product Description 20
Aptima HSV 1 & 2 Assay - Product Status 21
Aptima HSV 1 & 2 Assay - Product Description 21
Brevera Biopsy System - Product Status 22
Brevera Biopsy System - Product Description 22
Cytology System - Product Status 23
Cytology System - Product Description 23
Diagnostic Assay - Coagulation Disorders - Product Status 24
Diagnostic Assay - Coagulation Disorders - Product Description 24
Diagnostic Assay - HBV - Product Status 25
Diagnostic Assay - HBV - Product Description 25
Diagnostic Assay - HCV - Product Status 26
Diagnostic Assay - HCV - Product Description 26
Diagnostic Assay - Women's Health - Product Status 27
Diagnostic Assay - Women's Health - Product Description 27
Gene-Based Markers - Prostate Cancer - Product Status 28
Gene-Based Markers - Prostate Cancer - Product Description 28
Invader CYP2C9 And VKORC1 DNA Assay - Product Status 29
Invader CYP2C9 And VKORC1 DNA Assay - Product Description 29
LBC Automation Standalone Instrument - Product Status 30
LBC Automation Standalone Instrument - Product Description 30
MRSA Nucleic Acid Test - Product Status 31
MRSA Nucleic Acid Test - Product Description 31
Next Generation Panther Fusion - Product Status 32
Next Generation Panther Fusion - Product Description 32
Panther Fusion - Paraflu Assay - Product Status 33
Panther Fusion - Paraflu Assay - Product Description 33
Panther System - HSV-2 Assay - Product Status 34
Panther System - HSV-2 Assay - Product Description 34
PANTHER System - Virology - Product Status 35
PANTHER System - Virology - Product Description 35
Procleix Panther system - Product Status 36
Procleix Panther system - Product Description 36
Procleix Panther system - Evaluation of Sensitivity and Specificity of the Blood Donation Screening Test(Procleix Zika Virus Assay) 37
Procleix Zika Virus Assay - Product Status 38
Procleix Zika Virus Assay - Product Description 38
Procleix Zika Virus Assay - Evaluation of Sensitivity and Specificity of the Blood Donation Screening Test(Procleix Zika Virus Assay) 39
Quant. fFN Test - Product Status 40
Quant. fFN Test - Product Description 40
Real Time PCR Next Generation PANTHER System - Product Status 41
Real Time PCR Next Generation PANTHER System - Product Description 41
Second-Generation Prostate Cancer Assay - Product Status 42
Second-Generation Prostate Cancer Assay - Product Description 42
STAT Testing - Product Status 43
STAT Testing - Product Description 43
Hologic Inc, Key Employees 45
Hologic Inc, Key Employee Biographies 46
Hologic Inc, Other Locations 47
Hologic Inc, Subsidiaries 47
Hologic Inc, Affiliate 50
Glossary 59
List of Figures
Hologic Inc Pipeline Products by Equipment Type 7
Hologic Inc Pipeline Products by Development Stage 14
Hologic Inc Ongoing Clinical Trials by Trial Status 16
